BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31020423)

  • 1. Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection.
    Merrick GS; Tennant A; Fiano R; Bennett A; Anderson R; Galbreath R; Butler WM; Adamovich E
    World J Urol; 2020 Feb; 38(2):361-369. PubMed ID: 31020423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
    Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
    Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
    Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
    Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
    Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
    Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age on prostate cancer progression and quality of life in active surveillance patients.
    Merrick GS; Rohmann G; Galbreath R; Scholl W; Fiano R; Bennett A; Butler WM; Adamovich E
    BJUI Compass; 2021 Mar; 2(2):86-91. PubMed ID: 35474886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.
    Merrick GS; Galbreath R; Fiano R; Scholl W; Bennett A; Butler WM; Kurko B; Adamovich E
    Am J Clin Oncol; 2021 Aug; 44(8):429-433. PubMed ID: 34091475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
    Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
    World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.
    Miah S; Eldred-Evans D; Simmons LAM; Shah TT; Kanthabalan A; Arya M; Winkler M; McCartan N; Freeman A; Punwani S; Moore CM; Emberton M; Ahmed HU
    J Urol; 2018 Dec; 200(6):1235-1240. PubMed ID: 29940251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pelvic MRI combined with TRUS-guided transperineal template mapping biopsy for the diagnosis of prostate cancer].
    Li Q; Xie JJ; Cao WZ; Deng JP; Liu C; Cui Y; Shao Q; Shen H
    Zhonghua Nan Ke Xue; 2019 May; 25(5):408-413. PubMed ID: 32216225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications of transperineal template-guided prostate mapping biopsy].
    Wang F; Ding XF; Xu JN; Xu YZ; Zhou YQ; Luan Y; Lu SM; Tao HZ
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):428-431. PubMed ID: 30786336
    [No Abstract]   [Full Text] [Related]  

  • 12. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
    Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
    Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance--How Many Cores are Enough?
    Pham KN; Porter CR; Odem-Davis K; Wolff EM; Jeldres C; Wei JT; Morgan TM
    J Urol; 2015 Sep; 194(3):674-9. PubMed ID: 25963186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
    Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
    Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
    Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
    BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The morbidity of transperineal template-guided prostate mapping biopsy.
    Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
    BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
    Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
    Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy.
    Song W; Kang M; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    Investig Clin Urol; 2019 Nov; 60(6):454-462. PubMed ID: 31692988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
    Gershman B; Zietman AL; Feldman AS; McDougal WS
    Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.